2022
DOI: 10.1111/jpc.16165
|View full text |Cite
|
Sign up to set email alerts
|

Hope in the uncertainties and certainty for parents of children with rare neurological disorders. Part I (of 3): Uncertainty

Abstract: This is the first of three articles exploring the aspects of clinical care for children with rare neurological disorders including uncertainties old and new. The disruptive technologies of genomic sequencing and advanced therapeutics such as gene‐based therapies offer parents of children with severe but rare neurological conditions for the first‐time unprecedented opportunities for ‘precision medicine’. At the same time, the realities of limited genomic diagnostic yields and not infrequent detection of variant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 42 publications
0
6
0
Order By: Relevance
“…[40] Palmer et al believe that advanced therapies, such as genome sequencing technology and gene therapy, provide unprecedented precision medical opportunities for parents of children with severe but rare neurological diseases. [41] Smith et al strongly recommended genetic testing for all patients with unexplained epilepsy. [42]…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[40] Palmer et al believe that advanced therapies, such as genome sequencing technology and gene therapy, provide unprecedented precision medical opportunities for parents of children with severe but rare neurological diseases. [41] Smith et al strongly recommended genetic testing for all patients with unexplained epilepsy. [42]…”
Section: Discussionmentioning
confidence: 99%
“…[40] Palmer et al believe that advanced therapies, such as genome sequencing technology and gene therapy, provide unprecedented precision medical opportunities for parents of children with severe but rare neurological diseases. [41] Smith et al strongly recommended genetic testing for all patients with unexplained epilepsy. [42] In the # 5 "copy number variation" cluster, it was discussed that partial deoxyribonucleic acid fragment variation is the genetic cause of epilepsy or epilepsy-comorbid autism.…”
Section: Gene Detection and Mutationmentioning
confidence: 99%
“…In our last paper, 12 we looked at the range and types of uncertainty and, with them, some of the different types of certainty (see Fig. 1).…”
Section: The Increasingly Certain Journey Of Parental Carementioning
confidence: 99%
“…This is the sort of hopefulness that clinicians need to have and to offer as they share the journey. 10,11 In our last paper, 12 we looked at the range and types of uncertainty and, with them, some of the different types of certainty (see Fig. 1).…”
Section: The Increasingly Certain Journey Of Parental Carementioning
confidence: 99%
“…We have seen in the first two articles 1,2 in this three-part series that uncertainty and certainty around life-limiting, deeply distressing and relationship-impairing paediatric neurological disorders can provide formidable challenges to personal hopefulness for parents, families as well as the affected child. This hopelessness can consolidate into an active despair and bleed into the clinical team's capacity to help professionally and hope personally.…”
Section: A Credible and Meaningful Hopefulness In The Irreducibly Tragicmentioning
confidence: 99%